Select therapeutic use:
Indications for Betaxolol HCl Ophthalmic Solution:
Open-angle glaucoma. Ocular hypertension.
1–2 drops in affected eye(s) twice daily. Concomitant therapy with pilocarpine and other miotics, and/or epinephrine and/or carbonic anhydrase inhibitors can be instituted if needed.
Sinus bradycardia. Greater than 1st-degree AV block. Cardiogenic shock. Overt cardiac failure.
History of cardiac failure or heart block. Discontinue at 1st sign of cardiac failure. Asthma. Pulmonary impairment. Diabetes (esp. labile). May mask hypoglycemia and hyperthyroidism. May potentiate muscle weakness. Discontinue before general anesthesia. Avoid abrupt cessation. Pregnancy (Cat.C). Nursing mothers.
May potentiate or be potentiated by systemic β-blockers. May potentiate reserpine, hypoglycemics. May antagonize adrenergic psychotropics.
Transient discomfort, tearing. Rarely: decreased corneal sensitivity, erythema, itch, corneal punctate staining, keratitis, anisocoria, photophobia, depression, headache, bradycardia, dyspnea, hives.
Formerly known under the brand name Betoptic.
Soln—5mL, 10mL, 15mL